Ionic dysregulatory phenotyping of pathologic retinal thinning with manganese-enhanced MRI
- PMID: 18362105
- PMCID: PMC2517149
- DOI: 10.1167/iovs.08-1720
Ionic dysregulatory phenotyping of pathologic retinal thinning with manganese-enhanced MRI
Abstract
Purpose: To test the hypothesis that manganese-enhanced MRI (MEMRI) provides a sensitive and robust measure of an important retinal ionic dysregulatory phenotype in pathologic retinal thinning.
Methods: Four hours after intraperitoneal MnCl(2) injection, high-resolution MEMRI data were collected from overnight dark-adapted male control Sprague-Dawley and albino Royal College of Surgeons rats before (at development stage postnatal day [P] 17) and during photoreceptor degeneration (P36 and P57). In separate experiments, control rats, with and without repetitive hypoxic preconditioning, were subjected to high IOP (100 mm Hg) for 60 minutes followed by 24 hours or 7 days of reperfusion (e.g., ischemia/reperfusion). Central retinal thickness and intraretinal ion activity were measured from the MEMRI data. Histology examination was also performed to confirm retinal damage.
Results: In two different neurodegenerative models, MEMRI revealed first-time evidence for changes (P < 0.05) in intraretinal ion regulation before and during pathologic, but not (P > 0.05) developmental, retinal thinning. This phenotype was significantly altered by a neuroprotective repetitive hypoxic preconditioning protocol.
Conclusions: MEMRI and a nontoxic systemic dose of MnCl(2) provided an objective, noninvasive measure of an ionic deregulatory phenotype that appears useful for improved early diagnosis and treatment prognosis in a range of neurodegenerative diseases and their treatment.
Figures




Similar articles
-
Manganese-enhanced MRI reveals multiple cellular and vascular layers in normal and degenerated retinas.J Magn Reson Imaging. 2011 Dec;34(6):1422-9. doi: 10.1002/jmri.22719. Epub 2011 Sep 30. J Magn Reson Imaging. 2011. PMID: 21964629 Free PMC article.
-
Manganese-enhanced MRI studies of alterations of intraretinal ion demand in models of ocular injury.Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3796-804. doi: 10.1167/iovs.06-1278. Invest Ophthalmol Vis Sci. 2007. PMID: 17652754 Free PMC article.
-
Manganese-enhanced MRI optic nerve tracking: effect of intravitreal manganese dose on retinal toxicity.NMR Biomed. 2012 Dec;25(12):1360-8. doi: 10.1002/nbm.2808. Epub 2012 May 10. NMR Biomed. 2012. PMID: 22573611
-
Manganese-enhanced MRI: an exceptional tool in translational neuroimaging.Schizophr Bull. 2008 Jul;34(4):595-604. doi: 10.1093/schbul/sbn056. Epub 2008 Jun 11. Schizophr Bull. 2008. PMID: 18550591 Free PMC article. Review.
-
Retinal degeneration and local oxygen metabolism.Exp Eye Res. 2005 Jun;80(6):745-51. doi: 10.1016/j.exer.2005.01.018. Exp Eye Res. 2005. PMID: 15939030 Review.
Cited by
-
Intraretinal calcium channels and retinal morbidity in experimental retinopathy of prematurity.Mol Vis. 2011;17:2516-26. Epub 2011 Sep 27. Mol Vis. 2011. PMID: 21976962 Free PMC article.
-
Light-dependant intraretinal ion regulation by melanopsin in young awake and free moving mice evaluated with manganese-enhanced MRI.Mol Vis. 2010 Aug 30;16:1776-80. Mol Vis. 2010. PMID: 20808732 Free PMC article.
-
Manganese Enhanced MRI for Use in Studying Neurodegenerative Diseases.Front Neural Circuits. 2019 Jan 7;12:114. doi: 10.3389/fncir.2018.00114. eCollection 2018. Front Neural Circuits. 2019. PMID: 30666190 Free PMC article. Review.
-
Applications of Manganese-Enhanced Magnetic Resonance Imaging in Ophthalmology and Visual Neuroscience.Front Neural Circuits. 2019 May 14;13:35. doi: 10.3389/fncir.2019.00035. eCollection 2019. Front Neural Circuits. 2019. PMID: 31156399 Free PMC article. Review.
-
MRI biomarkers for evaluation of treatment efficacy in preclinical diabetic retinopathy.Expert Opin Med Diagn. 2013 Jul;7(4):393-403. doi: 10.1517/17530059.2013.814639. Epub 2013 Jun 21. Expert Opin Med Diagn. 2013. PMID: 23786440 Free PMC article. Review.
References
-
- Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004;23:91–147. - PubMed
-
- Ohguro H, Ohguro I, Mamiya K, Maeda T, Nakazawa M. Prolonged survival of the phosphorylated form of rhodopsin during dark adaptation of Royal College Surgeons rat. FEBS Lett. 2003;551:128–132. - PubMed
-
- Kalloniatis M, Tomisich G, Wellard JW, Foster LE. Mapping photoreceptor and postreceptoral labelling patterns using a channel permeable probe (agmatine) during development in the normal and RCS rat retina. Vis Neurosci. 2002;19:61–70. - PubMed
-
- Fox DA, Poblenz AT, He L, Harris JB, Medrano CJ. Pharmacological strategies to block rod photoreceptor apoptosis caused by calcium overload: a mechanistic target-site approach to neuroprotection. Eur J Ophthalmol. 2003;13 suppl 3:S44–S56. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical